NCT03173092 2026-05-04A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)TakedaPhase 4 Terminated141 enrolled